Portal de investigación
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia.
Datos básicos
Documentos
- No hay documentos
Grupos
Financiadores - Promotores
BIOGEN IDEC RESEARCH LIMITED
Cita
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Safety, and Tolerability of BIIB080 in Subjects with Mild Cognitive Impairment Due to Alzheimer’s Disease or Mild Alzheimer’s Disease Dementia. (247AD201). BIOGEN IDEC RESEARCH LIMITED. 2023IP:MIGUEL BAQUERO TOLEDO.